Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

(2021) Jörg Beyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors

(2019) Hiten D. Patel et al.   CANCER

Impact of Primary Metastatic Bone Disease in Germ Cell Tumors: Results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study

(2016) C. Oing et al.   ANNALS OF ONCOLOGY

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options—An Analysis From the Global Germ Cell Cancer Group

(2016) Darren R. Feldman et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care—Registry data from an outcomes research project of the German Testicular Cancer Study Group

(2016) Christoph Seidel et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Testicular Cancer — Discoveries and Updates

(2014) Nasser H. Hanna et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors

(2011) Karin Oechsle et al.   EUROPEAN UROLOGY